Adverse drug reactions and off-label drug use in paediatric outpatients

Documenti analoghi

• Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
  di: Montastruc, Jean-Louis, et al.
  Pubblicazione: (2011)
• Trends of reporting of ‘serious’vs. ‘non-serious’ adverse drug reactions over time: a study in the French PharmacoVigilance Database
  di: Moulis, Guillaume, et al.
  Pubblicazione: (2012)
• Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol)
  di: Tavassoli, Neda, et al.
  Pubblicazione: (2009)
• Using a capture–recapture method to assess the frequency of adverse drug reactions in a French university hospital
  di: Lugardon, Stephanie, et al.
  Pubblicazione: (2006)
• Rituximab off-label use for immune diseases: assessing adverse events in a single-centre drug-utilization survey
  di: Sailler, Laurent, et al.
  Pubblicazione: (2008)